Financial statements Gilead Sciences Poland

Balance sheet of Gilead Sciences Poland

Company age:
Age:
15 y. 9 m. 15 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of GILEAD SCIENCES POLAND

Year
2018
2019
2020
2021
2022
2023
Total assets 240 404 299,72 179 790 142,28 332 728 338,66 336 955 844,03 205 615 186,59 397 604 178,47
A. Fixed assets 16 303 037,22 15 098 510,44 13 857 638,60 11 449 780,53 11 127 141,89 23 596 316,17
B. Current assets 224 101 262,50 164 691 631,84 318 870 700,06 325 506 063,50 194 488 044,70 374 007 862,30
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 240 404 299,72 179 790 142,28 332 728 338,66 336 955 844,03 205 615 186,59 397 604 178,47
A. Equity 52 662 893,03 59 705 354,95 72 239 858,53 94 249 441,02 117 758 215,72 130 446 129,40
B. Liabilities and provisions for liabilities 187 741 406,69 120 084 787,33 260 488 480,13 242 706 403,01 87 856 970,87 267 158 049,07
I. Long-term liabilities 3 083 861,86 4 011 944,42 4 557 539,21 4 636 519,92 4 420 453,54 6 120 334,53
II. Short-term liabilities 150 862 413,07 95 559 359,82 235 385 325,87 226 755 370,55 65 431 737,68 215 062 544,13
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.